Antiviral Drug Strategies
Erik De Clercq
John Wiley & Sons, Apr 8, 2011 - Medical - 426 pages
By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Targeting Integration Beyond Strand Transfer
From Saquinavir to Darunavir The Impact of 10 Years of Medicinal Chemistry on a Lethal Disease
Acyclicand Cyclic Nucleoside Phosphonates
HelicasePrimase Inhibitors A NewApproach
Lethal Mutagenesis asan Unconventional
Recent Progress in the Development of
Antiviral RNAi Howto Silence Viruses
Neuraminidase Inhibitors as AntiInfluenza
acid action acyclic addition Agents and Chemotherapy AIDS analogues Antimicrobial Agents antiretroviral antiviral activity antiviral drugs approach associated binding bioavailability cells cellular cidofovir Clercq clinical combination compared complex compounds Current cyclophilin demonstrated derivatives described discovery disease DNA polymerase dose effects efficacy enzyme esters evaluation expression Figure function gene genome HCMV hepatitis herpes herpesvirus highly human cytomegalovirus human immunodeficiency immunodeficiency virus important incorporation increased infection influenza inhibition integrase interaction inthe isolates Journal Journalof kinase maribavir mechanism Medicinal Chemistry mice Molecular mutations Nature neuraminidase novel nucleoside phosphonates observed ofthe oral patients pharmacokinetic phase potent prevent prodrugs protease inhibitors protein recently reduced replication reported resistance reverse transcriptase Reviews ribavirin RNAi Sciences selective sequence showed shown significant specific strains structure studies synthesis target tenofovir therapeutic therapy transplant treatment trial viral Virology viruses vitro